InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

Current share price for NSB : $0.070 0.01 (16.67%)+

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Investor Webinar 11 Jun 2026 12:50PM $0.059 $0.070 risen by 18.64%
$27 Change in substantial holding 9 Jun 2026 8:21AM $0.087 $0.070 fallen by 19.54%
$27 Becoming a substantial holder 3 Jun 2026 5:26PM $0.091 $0.070 fallen by 23.08%
$27 Change of Director's Interest Notice x2 2 Jun 2026 5:41PM $0.093 $0.070 fallen by 24.73%
$27 Section 708A Notice 1 Jun 2026 5:35PM $0.090 $0.070 fallen by 22.22%
$27 Application for quotation of securities - NSB 1 Jun 2026 5:30PM $0.090 $0.070 fallen by 22.22%
$27 Updated Presentation - Successful Results 26 May 2026 12:17PM $0.110 $0.070 fallen by 36.36%
$27 Remarkable Results from Patients treated with StemSmart 26 May 2026 9:30AM $0.094 $0.070 fallen by 25.53%
$27 Trading Halt 25 May 2026 9:44AM $0.094 $0.070 fallen by 25.53%
$27 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 8:46AM $0.110 $0.070 fallen by 36.36%
$27 StemSmart Manufacturing Scale-Up Transfer Advances 17 Mar 2026 9:38AM $0.088 $0.070 fallen by 20.45%
$27 Half Yearly Report and Accounts 25 Feb 2026 7:00PM $0.110 $0.070 fallen by 36.36%
$27 Company Presentation 16 Feb 2026 9:53AM $0.130 $0.070 fallen by 46.15%
$27 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 8:27AM $0.135 $0.070 fallen by 48.15%
$27 Successful Clinical Results Achieved under Special Access 13 Jan 2026 9:51AM $0.115 $0.070 fallen by 39.13%
$27 Trading Halt 9 Jan 2026 9:27AM $0.115 $0.070 fallen by 39.13%
$27 Results of Annual General Meeting 12 Nov 2025 3:06PM $0.135 $0.070 fallen by 48.15%
$27 Investor Webinar Update 12 Nov 2025 10:00AM $0.135 $0.070 fallen by 48.15%
$27 Fourth Patient Commences StemSmart MSC Treatment 11 Nov 2025 9:26AM $0.140 $0.070 fallen by 50%
$27 Clinical & Scientific Advisory Board Appointed 6 Nov 2025 9:28AM $0.125 $0.070 fallen by 44%
$27 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2025 9:10AM $0.115 $0.070 fallen by 39.13%
$27 AusBiotech Presentation 21 Oct 2025 9:23AM $0.140 $0.070 fallen by 50%
$27 First Patients Approved for Special Access Program 7 Oct 2025 9:27AM $0.155 $0.070 fallen by 54.84%
$27 Letter to Shareholders & Proxy Form 2 Oct 2025 10:15AM $0.160 $0.070 fallen by 56.25%
$27 Notice of Meeting & Proxy Form 2 Oct 2025 10:15AM $0.160 $0.070 fallen by 56.25%

1 - 25 of 405 results

Page 1 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.